Premium
Ferumoxytol vs. Gadolinium agents for contrast‐enhanced MRI: Thoughts on evolving indications, risks, and benefits
Author(s) -
Finn J. Paul,
Nguyen KimLien,
Hu Peng
Publication year - 2017
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.25580
Subject(s) - nephrogenic systemic fibrosis , medicine , gadolinium , ferumoxytol , magnetic resonance imaging , radiology , chemistry , organic chemistry